Skip to content

Effects of crocin in reducing DNA damage, inflammation, and oxidative stress in multiple sclerosis patients: A double-blind, randomized, and placebo-controlled trial.

Randomized controlled trial · J Biochem Mol Toxicol · 2019. Source record refreshed; an explanation has not been reviewed.

Randomized controlled trialSource: PubMed · PMID 31617649

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Publication details

Effects of crocin in reducing DNA damage, inflammation, and oxidative stress in multiple sclerosis patients: A double-blind, randomized, and placebo-controlled trial.

Ghiasian M, Khamisabadi F, Kheiripour N et al.
J Biochem Mol Toxicol · 2019

PubMed ID
31617649
Record checked

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.